rs34038364

Variant summary

Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_002253.4(KDR):​c.2066C>T​(p.Thr689Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00332 in 1,613,602 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0029 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0034 ( 12 hom. )

Consequence

KDR
NM_002253.4 missense

Scores

18

Clinical Significance

Benign criteria provided, single submitter U:1B:2O:1

Conservation

PhyloP100: -0.0930
Variant links:
Genes affected
KDR (HGNC:6307): (kinase insert domain receptor) Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas. [provided by RefSeq, May 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0052033663).
BP6
Variant 4-55102430-G-A is Benign according to our data. Variant chr4-55102430-G-A is described in ClinVar as [Benign]. Clinvar id is 134606.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr4-55102430-G-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 443 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
KDRNM_002253.4 linkuse as main transcriptc.2066C>T p.Thr689Met missense_variant 14/30 ENST00000263923.5

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
KDRENST00000263923.5 linkuse as main transcriptc.2066C>T p.Thr689Met missense_variant 14/301 NM_002253.4 P1P35968-1
KDRENST00000647068.1 linkuse as main transcriptn.2079C>T non_coding_transcript_exon_variant 14/30

Frequencies

GnomAD3 genomes
AF:
0.00291
AC:
443
AN:
152138
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000772
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.00242
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0138
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00322
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00319
AC:
800
AN:
251160
Hom.:
7
AF XY:
0.00297
AC XY:
403
AN XY:
135738
show subpopulations
Gnomad AFR exome
AF:
0.000738
Gnomad AMR exome
AF:
0.00258
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0152
Gnomad NFE exome
AF:
0.00296
Gnomad OTH exome
AF:
0.00523
GnomAD4 exome
AF:
0.00336
AC:
4916
AN:
1461346
Hom.:
12
Cov.:
32
AF XY:
0.00322
AC XY:
2344
AN XY:
726994
show subpopulations
Gnomad4 AFR exome
AF:
0.000389
Gnomad4 AMR exome
AF:
0.00242
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.0136
Gnomad4 NFE exome
AF:
0.00349
Gnomad4 OTH exome
AF:
0.00310
GnomAD4 genome
AF:
0.00291
AC:
443
AN:
152256
Hom.:
1
Cov.:
32
AF XY:
0.00353
AC XY:
263
AN XY:
74440
show subpopulations
Gnomad4 AFR
AF:
0.000770
Gnomad4 AMR
AF:
0.00242
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0138
Gnomad4 NFE
AF:
0.00322
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00287
Hom.:
1
Bravo
AF:
0.00209
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00407
AC:
35
ExAC
AF:
0.00287
AC:
349
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00327
EpiControl
AF:
0.00344

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:2Other:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingInvitaeDec 31, 2019- -
Likely benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The KDR p.Thr689Met variant was not identified in the literature but was identified in dbSNP (ID: rs34038364), ClinVar (classified as uncertain significance by Department of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC/University of Seville) and LOVD 3.0 (classified as likely benign). The variant was identified in control databases in 916 of 282566 chromosomes (7 homozygous) at a frequency of 0.003242 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: European (Finnish) in 370 of 25118 chromosomes (freq: 0.01473), Other in 40 of 7210 chromosomes (freq: 0.005548), European (non-Finnish) in 392 of 128968 chromosomes (freq: 0.00304), Latino in 92 of 35386 chromosomes (freq: 0.0026), African in 21 of 24964 chromosomes (freq: 0.000841) and Ashkenazi Jewish in 1 of 10360 chromosomes (freq: 0.000097), but was not observed in the East Asian or South Asian populations. The p.Thr689 residue is not conserved in mammals and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -
Hirschsprung disease, susceptibility to, 1 Uncertain:1
Uncertain significance, no assertion criteria providedresearchDepartment of Genetics, Reproduction and Fetal Medicine., Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC/University of Seville.Apr 01, 2015- -
not specified Other:1
not provided, no classification providedreference populationITMISep 19, 2013- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
8.5
DANN
Benign
0.87
DEOGEN2
Benign
0.11
T;T
Eigen
Benign
-0.99
Eigen_PC
Benign
-0.94
FATHMM_MKL
Benign
0.15
N
LIST_S2
Benign
0.36
.;T
MetaRNN
Benign
0.0052
T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.97
L;L
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.17
.;N
REVEL
Benign
0.044
Sift
Benign
0.14
.;T
Sift4G
Benign
0.12
.;T
Polyphen
0.025
B;B
Vest4
0.22
MVP
0.082
MPC
0.17
ClinPred
0.0020
T
GERP RS
3.3
Varity_R
0.13
gMVP
0.43

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34038364; hg19: chr4-55968597; COSMIC: COSV55779992; COSMIC: COSV55779992; API